Cochrane · systematic review · CD010054
Time course for blood pressure lowering of beta‐blockers with partial agonist activity
Zhang, X-Y, Soufi, S, Dormuth, C, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library
HypertensionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Beta‐blockers with partial agonist activity compared to no treatment for hypertension
Population: adults with essential hypertension
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks) Beta‐blockers with partial agonist activity vs no treatment | no estimate extracted | 121 participants | Very low |
Variation in the decrease in 24‐hour ambulatory hourly DBP (at 3 to 12 weeks) Beta‐blockers with partial agonist activity vs no treatment | no estimate extracted | 121 participants | Very low |
Variation in the decrease in 24‐hour ambulatory hourly HR (at 3 to 12 weeks) Beta‐blockers with partial agonist activity vs no treatment | no estimate extracted | 71 participants | Very low |